$DTIL
PRECISION BIOSCIENCES INC

2021 Q1 Form 10-Q Financial Statement

#000156459021027213 Filed on May 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $16.35M $7.000M
YoY Change 133.57% 28.16%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.500M $9.620M
YoY Change -1.25% 92.4%
% of Gross Profit
Research & Development $25.59M $23.04M
YoY Change 11.08% 15.43%
% of Gross Profit
Depreciation & Amortization $2.180M $2.160M
YoY Change 0.93% 129.79%
% of Gross Profit
Operating Expenses $25.59M $34.49M
YoY Change -25.8% 38.22%
Operating Profit -$27.50M
YoY Change 41.05%
Interest Expense $50.00K $660.0K
YoY Change -92.42% 262.64%
% of Operating Profit
Other Income/Expense, Net $660.0K
YoY Change -105.37%
Pretax Income -$18.69M -$26.84M
YoY Change -30.37% -15.54%
Income Tax
% Of Pretax Income
Net Earnings -$18.69M -$26.84M
YoY Change -30.36% -15.56%
Net Earnings / Revenue -114.31% -383.37%
Basic Earnings Per Share
Diluted Earnings Per Share -$330.0K -$523.1K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $193.5M $154.2M
YoY Change 25.49% 32.36%
Cash & Equivalents $193.5M $154.2M
Short-Term Investments
Other Short-Term Assets $6.400M $8.800M
YoY Change -27.27% 46.06%
Inventory
Prepaid Expenses
Receivables $19.30M $3.900M
Other Receivables $0.00 $0.00
Total Short-Term Assets $219.1M $166.8M
YoY Change 31.35% 21.77%
LONG-TERM ASSETS
Property, Plant & Equipment $40.00M $45.40M
YoY Change -11.89% 62.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.800M $600.0K
YoY Change 200.0% 32.45%
Total Long-Term Assets $43.20M $47.40M
YoY Change -8.86% 58.95%
TOTAL ASSETS
Total Short-Term Assets $219.1M $166.8M
Total Long-Term Assets $43.20M $47.40M
Total Assets $262.3M $214.2M
YoY Change 22.46% 28.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K $1.800M
YoY Change -77.78% -64.41%
Accrued Expenses $8.200M $8.700M
YoY Change -5.75% 128.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $63.80M $23.80M
YoY Change 168.07% -66.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $392.0K $75.40M
YoY Change -99.48% -10.87%
Total Long-Term Liabilities $392.0K $75.40M
YoY Change -99.48% -10.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $63.80M $23.80M
Total Long-Term Liabilities $392.0K $75.40M
Total Liabilities $203.5M $99.20M
YoY Change 105.14% -36.4%
SHAREHOLDERS EQUITY
Retained Earnings -$304.8M
YoY Change
Common Stock $364.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $952.0K
YoY Change
Treasury Stock Shares
Shareholders Equity $58.82M $115.0M
YoY Change
Total Liabilities & Shareholders Equity $262.3M $214.2M
YoY Change 22.46% 28.42%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$18.69M -$26.84M
YoY Change -30.36% -15.56%
Depreciation, Depletion And Amortization $2.180M $2.160M
YoY Change 0.93% 129.79%
Cash From Operating Activities $68.07M -$25.91M
YoY Change -362.72% 30.16%
INVESTING ACTIVITIES
Capital Expenditures -$1.130M -$1.100M
YoY Change 2.73% -78.35%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.125M -$1.103M
YoY Change 1.99% -78.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 36.72M 314.0K
YoY Change 11592.68% -99.18%
NET CHANGE
Cash From Operating Activities 68.07M -25.91M
Cash From Investing Activities -1.125M -1.103M
Cash From Financing Activities 36.72M 314.0K
Net Change In Cash 103.7M -26.70M
YoY Change -488.26% -300.65%
FREE CASH FLOW
Cash From Operating Activities $68.07M -$25.91M
Capital Expenditures -$1.130M -$1.100M
Free Cash Flow $69.20M -$24.81M
YoY Change -378.93% 67.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1996000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
854000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1721000
CY2020Q4 us-gaap Assets
Assets
150158000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
792000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5745000
CY2020Q4 dtil Accrued Clinical And Research And Development Expenses
AccruedClinicalAndResearchAndDevelopmentExpenses
3269000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8586000
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
952000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
952000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
58822000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44425000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
262316000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
150158000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
392000
CY2021Q1 us-gaap Liabilities
Liabilities
203494000
CY2020Q4 us-gaap Liabilities
Liabilities
105733000
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
364536000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
331450000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-304762000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-286073000
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2030000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8062000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
392000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
115034000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-266000
CY2021Q1 dtil Increase Decrease In Accrued Other Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedOtherExpensesAndOtherCurrentLiabilities
-2146000
CY2020Q1 dtil Increase Decrease In Accrued Other Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedOtherExpensesAndOtherCurrentLiabilities
-916000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
92914000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3139000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3632000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3105000
CY2021Q1 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-23000
CY2021Q1 dtil Amortization Of Right Of Use Asset
AmortizationOfRightOfUseAsset
290000
CY2020Q1 dtil Amortization Of Right Of Use Asset
AmortizationOfRightOfUseAsset
235000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
619000
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1635000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9263000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2894000
CY2021Q1 dtil Increase Decrease In Other Assets And Other Current Assets
IncreaseDecreaseInOtherAssetsAndOtherCurrentAssets
6000
CY2020Q1 dtil Increase Decrease In Other Assets And Other Current Assets
IncreaseDecreaseInOtherAssetsAndOtherCurrentAssets
-1411000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
221000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
53000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
660000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18689000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-26836000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.52
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56625024
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51312770
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
138314000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
212000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
239000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3105000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1297000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
418000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3632000
CY2021Q1 dtil Stock Issued During Period Value Collaboration Partners
StockIssuedDuringPeriodValueCollaborationPartners
27739000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-18689000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-26836000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2176000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2155000
CY2021Q1 dtil Increase Decrease In Lease Liability And Right To Use Asset Other Than Amortization Net
IncreaseDecreaseInLeaseLiabilityAndRightToUseAssetOtherThanAmortizationNet
461000
CY2020Q1 dtil Increase Decrease In Lease Liability And Right To Use Asset Other Than Amortization Net
IncreaseDecreaseInLeaseLiabilityAndRightToUseAssetOtherThanAmortizationNet
400000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
68072000
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1125000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1125000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1297000
CY2021Q1 dtil Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
418000
CY2021Q1 dtil Proceeds From Issuance Of Common Stock To Collaboration Partners
ProceedsFromIssuanceOfCommonStockToCollaborationPartners
35000000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36715000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
103662000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89798000
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
637000
CY2020Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
66000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M4D
CY2021Q1 dtil Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Fair Value Per Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageFairValuePerOption
8.32
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10544270
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
106186
CY2021Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2006-01-26
CY2021Q1 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
2900
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
11000000
CY2019Q2 dtil Common And Preferred Stocks Shares Authorized
CommonAndPreferredStocksSharesAuthorized
210000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000005
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q1 dtil Share Based Compensation Expense Related To Espp
ShareBasedCompensationExpenseRelatedToESPP
100000
CY2019Q1 dtil Share Based Compensation Expense Related To Espp
ShareBasedCompensationExpenseRelatedToESPP
100000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3632000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3105000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7369
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0066
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
676791
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
170316
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9803349
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.88
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.66
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.92
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
10.92
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.29
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6800000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2100000
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
27100000
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
491000
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
87000
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
236000
CY2021Q1 us-gaap Lease Cost
LeaseCost
814000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
665000
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2022000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2769000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2848000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2134000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1086000
CY2021Q1 dtil Lessee Operating Lease Liability Payments Due In Five Years And Therafter
LesseeOperatingLeaseLiabilityPaymentsDueInFiveYearsAndTherafter
1108000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11967000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1909000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
10058000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2

Files In Submission

Name View Source Status
0001564590-21-027213-index-headers.html Edgar Link pending
0001564590-21-027213-index.html Edgar Link pending
0001564590-21-027213.txt Edgar Link pending
0001564590-21-027213-xbrl.zip Edgar Link pending
dtil-10q_20210331.htm Edgar Link pending
dtil-20210331.xml Edgar Link completed
dtil-20210331.xsd Edgar Link pending
dtil-20210331_cal.xml Edgar Link unprocessable
dtil-20210331_def.xml Edgar Link unprocessable
dtil-20210331_lab.xml Edgar Link unprocessable
dtil-20210331_pre.xml Edgar Link unprocessable
dtil-ex101_169.htm Edgar Link pending
dtil-ex102_118.htm Edgar Link pending
dtil-ex103_117.htm Edgar Link pending
dtil-ex104_317.htm Edgar Link pending
dtil-ex105_291.htm Edgar Link pending
dtil-ex311_170.htm Edgar Link pending
dtil-ex312_173.htm Edgar Link pending
dtil-ex321_171.htm Edgar Link pending
dtil-ex322_172.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending